AstraZeneca (AZN)
(Real Time Quote from BATS)
$75.21 USD
+0.18 (0.24%)
Updated Apr 26, 2024 03:39 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 21% (198 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.38 | 2.10 | 9.99 |
Current Quarter Estimate | 0.99 | 37.64 | 60.00 |
Year Ago Quarter Estimate | 1.08 | 11.39 | 52.54 |
Next Quarter Estimate | 1.06 | 34.85 | 61.00 |
Next Year Estimate | 4.65 | 178.47 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 10.47 | 3.90 | 17.08 |
Next Year | 15.96 | 16.10 | 8.00 |
Last 5 Years | 14.00 | 3.00 | 8.10 |
Next 5 Years | 13.60 | 11.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 20.22 | 15.53 |
Price/Book (MRQ) | 5.94 | 5.30 |
Price/Cash Flow (MRFY) | 13.90 | 10.16 |
Dividend Yield | 2.57% | 2.85% |
Net Profit Margin (TTM) | 13.30% | 45.26% |
Return on Equity (TTM) | 30.34% | 36.43% |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.